198 related articles for article (PubMed ID: 34780266)
21. Whole genome sequencing reveals candidate genes involving in PAS resistance in M. Tuberculosis isolated from patients in Thailand.
Dokladda K; Billamas P; Jaitrong S; Suwanakitti N; Phornsiricharoenphant W; Viratyosin W; Prammananan T
World J Microbiol Biotechnol; 2023 Dec; 40(1):32. PubMed ID: 38057660
[TBL] [Abstract][Full Text] [Related]
22. Genome-wide DNA methylation and transcriptome and proteome changes in Mycobacterium tuberculosis with para-aminosalicylic acid resistance.
Li HC; Chen T; Yu L; Guo HX; Chen L; Chen YH; Chen M; Zhao J; Yan HM; Zhou L; Wang W
Chem Biol Drug Des; 2020 Jan; 95(1):104-112. PubMed ID: 31562690
[TBL] [Abstract][Full Text] [Related]
23. Anti-folates potentiate bactericidal effects of other antimicrobial agents.
Li K; Wang XD; Yang SS; Gu J; Deng JY; Zhang XE
J Antibiot (Tokyo); 2017 Mar; 70(3):285-291. PubMed ID: 28074051
[TBL] [Abstract][Full Text] [Related]
24. Rational Design of Biosafety Level 2-Approved, Multidrug-Resistant Strains of Mycobacterium tuberculosis through Nutrient Auxotrophy.
Vilchèze C; Copeland J; Keiser TL; Weisbrod T; Washington J; Jain P; Malek A; Weinrick B; Jacobs WR
mBio; 2018 May; 9(3):. PubMed ID: 29844114
[TBL] [Abstract][Full Text] [Related]
25. The folate pathway is a target for resistance to the drug para-aminosalicylic acid (PAS) in mycobacteria.
Rengarajan J; Sassetti CM; Naroditskaya V; Sloutsky A; Bloom BR; Rubin EJ
Mol Microbiol; 2004 Jul; 53(1):275-82. PubMed ID: 15225321
[TBL] [Abstract][Full Text] [Related]
26. A combination screening to identify enhancers of para-aminosalicylic acid against Mycobacterium tuberculosis.
Heo J; Koh D; Woo M; Kwon D; de Almeida Falcão VC; Wood C; Lee H; Kim K; Choi I; Jang J; Brodin P; Shum D; Delorme V
Sci Rep; 2022 Apr; 12(1):5635. PubMed ID: 35379873
[TBL] [Abstract][Full Text] [Related]
27. Biochemical and genetic analysis of methylenetetrahydrofolate reductase in Leishmania metabolism and virulence.
Vickers TJ; Orsomando G; de la Garza RD; Scott DA; Kang SO; Hanson AD; Beverley SM
J Biol Chem; 2006 Dec; 281(50):38150-8. PubMed ID: 17032644
[TBL] [Abstract][Full Text] [Related]
28. Mutations of folC cause increased susceptibility to sulfamethoxazole in Mycobacterium tuberculosis.
Wang R; Li K; Yu J; Deng J; Chen Y
Sci Rep; 2021 Jan; 11(1):1352. PubMed ID: 33446754
[TBL] [Abstract][Full Text] [Related]
29. Knocking out salicylate biosynthesis genes in Mycobacterium smegmatis induces hypersensitivity to p-aminosalicylate (PAS).
Nagachar N; Ratledge C
FEMS Microbiol Lett; 2010 Oct; 311(2):193-9. PubMed ID: 20735479
[TBL] [Abstract][Full Text] [Related]
30. Genetic determinants involved in p-aminosalicylic acid resistance in clinical isolates from tuberculosis patients in northern China from 2006 to 2012.
Zhang X; Liu L; Zhang Y; Dai G; Huang H; Jin Q
Antimicrob Agents Chemother; 2015 Feb; 59(2):1320-4. PubMed ID: 25421465
[TBL] [Abstract][Full Text] [Related]
31. Role of Whole-Genome Sequencing in Characterizing the Mechanism of Action of
Satta G; Witney AA; Begum N; Ortiz Canseco J; Boa AN; McHugh TD
Antimicrob Agents Chemother; 2020 Aug; 64(9):. PubMed ID: 32571810
[No Abstract] [Full Text] [Related]
32. Competition between H
Yu JF; Xu JT; Feng A; Qi BL; Gu J; Deng JY; Zhang XE
Antibiotics (Basel); 2023 Dec; 13(1):. PubMed ID: 38275323
[TBL] [Abstract][Full Text] [Related]
33. Mycobacterium tuberculosis thymidylate synthase gene thyX is essential and potentially bifunctional, while thyA deletion confers resistance to p-aminosalicylic acid.
Fivian-Hughes AS; Houghton J; Davis EO
Microbiology (Reading); 2012 Feb; 158(Pt 2):308-318. PubMed ID: 22034487
[TBL] [Abstract][Full Text] [Related]
34. Antimycobacterial pyridine carboxamides: From design to in vivo activity.
Nawrot DE; Bouz G; Janďourek O; Konečná K; Paterová P; Bárta P; Novák M; Kučera R; Zemanová J; Forbak M; Korduláková J; Pavliš O; Kubíčková P; Doležal M; Zitko J
Eur J Med Chem; 2023 Oct; 258():115617. PubMed ID: 37423128
[TBL] [Abstract][Full Text] [Related]
35. Analysis of mutations leading to para-aminosalicylic acid resistance in Mycobacterium tuberculosis.
Pandey B; Grover S; Kaur J; Grover A
Sci Rep; 2019 Sep; 9(1):13617. PubMed ID: 31541138
[TBL] [Abstract][Full Text] [Related]
36. [Incidence of wild strains of Mycobacterium tuberculosis in variants resistant to minor antibiotics (p-aminosalicylic acid, ethionamide, cycloserine, viomycin, kanamycin)].
GROSSET J; CANETTI G
Ann Inst Pasteur (Paris); 1962 Aug; 103():163-84. PubMed ID: 13902273
[No Abstract] [Full Text] [Related]
37. Antibiotic Susceptibility Patterns of Mycobacterium tuberculosis Isolates from Guizhou Province of China Against 13 Antituberculosis Drugs.
Li N; Liao X; Chen L; Wang J; Liu M; Zhang H
Microb Drug Resist; 2015 Jun; 21(3):292-6. PubMed ID: 25599413
[TBL] [Abstract][Full Text] [Related]
38. Matrix metalloproteinase-1 is regulated in tuberculosis by a p38 MAPK-dependent, p-aminosalicylic acid-sensitive signaling cascade.
Rand L; Green JA; Saraiva L; Friedland JS; Elkington PT
J Immunol; 2009 May; 182(9):5865-72. PubMed ID: 19380835
[TBL] [Abstract][Full Text] [Related]
39. [The rates of resistance to second-line drugs in multidrug resistant Mycobacterium tuberculosis strains].
Kayali R; Cöplü N; Ceyhan I; Ocak F; Citil BE; Esen B
Mikrobiyol Bul; 2006; 40(1-2):1-7. PubMed ID: 16775950
[TBL] [Abstract][Full Text] [Related]
40. Phylogenetic and Structural Significance of Dihydrofolate Synthase (folC) Mutations in Drug-Resistant Mycobacterium tuberculosis.
Cheng VW; Leung KS; Kwok JS; Leung RK; Yang KY; Chan RC; Kam KM; Tsui SK
Microb Drug Resist; 2016 Oct; 22(7):545-551. PubMed ID: 27082669
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
